BFLY

Butterfly Network, Inc. (BFLY) | Rumor.io

Butterfly Network

BFLY

Attention (50-day avg)0.01%

Attention rank (50-day avg)#650

Bullish sentiment (50-day avg)98%

Price to earnings ratio-29.5

Market capitalization2.4B

Earnings per share-0.29

Dividend yield (TTM)—

Revenue (annual)97.6M

Net income (annual)-77.1M

Social

What share of all stock conversation is about BFLY?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.01% 0	0% -0.01	0.01% +0	0% 0

Sep 29

Evercore ISI initiated coverage of Butterfly Network with an Outperform rating and $15 price target, citing the company's pioneering ultrasound-on-chip technology.
Butterfly Network's founder, Dr. Jonathan Rothberg, is applying the same technology to proteins, generating new biological data and using AI to turn it into knowledge.
The company's fourth-generation chip, produced by TSMC, is due to be released early next year, with higher image quality than traditional ultrasound, which was previously thought to be impossible.

Generated by AI

Sentiment

Of the messages about BFLY that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	88%	79.01% -20.74	97.56% +0.86	95.81% +5.39
Bearish	12%	20.99% +20.74	2.44% -0.86	4.19% -5.39

Bullish· Sep 22

The Butterfly Network's handheld ultrasound technology has the potential to expand into new medical-device markets beyond handheld ultrasound, as mentioned in the Needham report that started the stock at a buy with a $10 price target.
The stock's strong close above the daily gold zone is likely to trigger a strong bullish continuation, as seen in the past performance of the stock.
The stock's valuation may be stretched in the short term, but long-term bulls like the author are encouraged to keep buying the stock on any pullbacks, with the potential for a significant gain in the future.

Bearish· Jun 22

$BFLY's recent price action is a classic low-volume fakeout, with overnight spikes rarely holding once real volume comes in.
Butterfly Network's unprofitability persists, with a net loss of $12.7 million in Q1 2026 and no forecasted positive net earnings for the next few years.
$BFLY is overbought, overpriced, and overhyped, with a high percentage of short interest and a downtrend that's expected to continue, potentially reaching $6 or lower by the end of the week.

Generated by AI

Topics

Of the messages about BFLY that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	33.33%	13.29%	7%	43.53%
Technical Analysis	0%	7.59%	34.46%	30.45%
Analysts	66.67%	72.15%	57.33%	17.37%
Earnings	0%	0%	0.32%	3.12%
Controversies	0%	0%	0%	0.26%
Macro	0%	6.96%	0.89%	5.26%

Earnings· Feb 26

Butterfly Network reported Q4 2025 earnings with record revenue of $31.5M, a 41% YoY increase, and positive net cash flow of $6.3M.
The company's adjusted EPS was -$0.02, beating estimates, and its revenue guidance for FY2026 is $117M to $121M, representing 20% to 24% growth.
Butterfly Network's Q4 results marked the first quarter of positive operating cash flow and the lowest annual cash usage in company history, with the Midjourney partnership contributing $6.8M of revenue in Q4.

Analysts· Jun 21

Cowen initiates coverage on Butterfly Network with an Outperform rating and a price target of $20.
Analysts expect Butterfly Network's stock price to reach the $20's before long, potentially driven by inclusion in the Russell Index and further analyst coverage.
Butterfly Network's stock has a better rating than 84% of its industry peers.

Announcements· Jun 19

Butterfly Network's ($BFLY) shares surged on the announcement of Midjourney Medical's full-body scanner, which runs on Butterfly's Ultrasound-on-Chip technology.
The partnership between Midjourney and Butterfly Network has significant implications for the company's revenue streams, with potential earnings of up to $74M over five years.
The Midjourney Medical division's full-body scanner is being positioned as a consumer-friendly medical tool, potentially offering a faster and more accessible alternative to traditional MRI scans, although clinical accuracy and regulatory approval remain uncertain.

Technical Analysis· Feb 26

$BFLY has a potential run back to $5 or higher with a strong setup.
The stock is primed for continuation with bulls in control, and buyers dominate the tape.
$BFLY has broken out above recent swing highs, with a bid holding above support, and is playable for continuation.

Generated by AI

Community

Of the messages about BFLY, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	75.38%	44.71%	45.41%	37.21%
Newcomers	24.62%	55.29%	54.59%	62.79%

Regulars· Sep 22

Needham initiates coverage of Butterfly Network with a buy rating and a $10 target price, citing the company's potential to expand into new medical-device markets and its core platform's multiple near-term growth catalysts.
The stock is expected to reach double-digit prices by the end of the year, with some regulars predicting it will reach $10 before the close of the year.
The stock's valuation is considered stretched in the short term, but long-term bulls believe the company's growth prospects and potential for expansion into new markets will justify its current price.

Newcomers· Sep 22

The price of $BFLY has been increasing, with a 20.1% gain today, and a 150% increase over the past year, according to the daily and yearly charts.
The stock's recent move is attributed to analyst initiation, with Needham initiating coverage at Buy with a $10.00 price target, and the filing accounts for the stock's price increase.
$BFLY's market capitalization has been validated by the stock's recent price increase, with a current market cap of $2.6 billion, and the company's development and commercialization of ultrasound imaging solutions is seen as a key factor in its success.

Generated by AI

News

Evercore ISI initiates Butterfly Network stock with outperform rating

1d agoInvesting.com

Butterfly Network: Strong Stock Performance For This Innovative Company (NYSE:BFLY)

Butterfly's growth is fueled by Embedded partnerships, strong medical school adoption, Compass AI, and a robust US government pipeline. Read more on BFLY stock here.

2d agoSeeking Alpha

Butterfly Network president & CEO Joseph DeVivo sells $59,866 stock

5d agoInvesting.com

Butterfly Stock Retreats: What's Going On Today? - Butterfly Network (NYSE:BFLY)

Butterfly Network shares are falling Wednesday, pulling back after the stock soared Tuesday on a bullish analyst initiation.

6d agoBenzinga

Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains?

Butterfly Network (BFLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

7d agoYahoo Finance

Butterfly Network (BFLY) Gets New ‘Buy’ Reco, Climbs 22%; Hedge Fund Holdings More-Than-Double

7d agoYahoo Finance

Also Discussed

Investors talking about BFLY also mention

#	Name	Attention
1	Quantum-Si Incorporated Class A Common StockQSI	0.02%+0.02
2	Hyperfine, Inc. Class A Common StockHYPR	0%0
3	Nano-X Imaging Ltd. Ordinary SharesNNOX	0%0
4	DM - Desktop Metal, Inc.	——
5	Skillz Inc.SKLZ	0%new
6	BLFY - Blue Foundry Bancorp	——
7	ARK Genomic Revolution ETFARKG	0.25%+0.09
8	Seer, Inc. Class A Common StockSEER	0%0
9	Alpha Modus Holdings, Inc. Class A Common StockINAQ	0%0
10	Blade Air Mobility Inc.BLDE	0%new

Butterfly Network, Inc.

Healthcare
Medical Devices

Butterfly Network Inc. Class A Common Stock represents ownership in Butterfly Network, a healthcare technology company focused on portable ultrasound imaging solutions. Butterfly Network develops, manufactures, and commercializes handheld ultrasound devices and related software that support whole-body imaging at the point of care. Its product lineup includes the Butterfly iQ+ and iQ3 ultrasound systems, the Butterfly Move cart-based platform, and the iQ+ Bladder scanning solution, serving physicians and other licensed healthcare providers across hospitals, clinics, and other care settings. The company also offers cloud-connected software, workflow tools, and AI-enabled applications that help integrate imaging into clinical practice. Butterfly Network serves both U.S. and international markets, with products used in human and veterinary care, making it a notable participant in the medical devices and digital health segments of the healthcare market.

Website

Location

1600 District Avenue

Burlington, MA, 01803

United States

Social

What share of all stock conversation is about BFLY?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.01% 0	0% -0.01	0.01% +0	0% 0

Sep 29

Evercore ISI initiated coverage of Butterfly Network with an Outperform rating and $15 price target, citing the company's pioneering ultrasound-on-chip technology.
Butterfly Network's founder, Dr. Jonathan Rothberg, is applying the same technology to proteins, generating new biological data and using AI to turn it into knowledge.
The company's fourth-generation chip, produced by TSMC, is due to be released early next year, with higher image quality than traditional ultrasound, which was previously thought to be impossible.

Generated by AI

Sentiment

Of the messages about BFLY that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	88%	79.01% -20.74	97.56% +0.86	95.81% +5.39
Bearish	12%	20.99% +20.74	2.44% -0.86	4.19% -5.39

Bullish· Sep 22

The Butterfly Network's handheld ultrasound technology has the potential to expand into new medical-device markets beyond handheld ultrasound, as mentioned in the Needham report that started the stock at a buy with a $10 price target.
The stock's strong close above the daily gold zone is likely to trigger a strong bullish continuation, as seen in the past performance of the stock.
The stock's valuation may be stretched in the short term, but long-term bulls like the author are encouraged to keep buying the stock on any pullbacks, with the potential for a significant gain in the future.

Bearish· Jun 22

$BFLY's recent price action is a classic low-volume fakeout, with overnight spikes rarely holding once real volume comes in.
Butterfly Network's unprofitability persists, with a net loss of $12.7 million in Q1 2026 and no forecasted positive net earnings for the next few years.
$BFLY is overbought, overpriced, and overhyped, with a high percentage of short interest and a downtrend that's expected to continue, potentially reaching $6 or lower by the end of the week.

Generated by AI

Topics

Of the messages about BFLY that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	33.33%	13.29%	7%	43.53%
Technical Analysis	0%	7.59%	34.46%	30.45%
Analysts	66.67%	72.15%	57.33%	17.37%
Earnings	0%	0%	0.32%	3.12%
Controversies	0%	0%	0%	0.26%
Macro	0%	6.96%	0.89%	5.26%

Earnings· Feb 26

Butterfly Network reported Q4 2025 earnings with record revenue of $31.5M, a 41% YoY increase, and positive net cash flow of $6.3M.
The company's adjusted EPS was -$0.02, beating estimates, and its revenue guidance for FY2026 is $117M to $121M, representing 20% to 24% growth.
Butterfly Network's Q4 results marked the first quarter of positive operating cash flow and the lowest annual cash usage in company history, with the Midjourney partnership contributing $6.8M of revenue in Q4.

Analysts· Jun 21

Cowen initiates coverage on Butterfly Network with an Outperform rating and a price target of $20.
Analysts expect Butterfly Network's stock price to reach the $20's before long, potentially driven by inclusion in the Russell Index and further analyst coverage.
Butterfly Network's stock has a better rating than 84% of its industry peers.

Announcements· Jun 19

Butterfly Network's ($BFLY) shares surged on the announcement of Midjourney Medical's full-body scanner, which runs on Butterfly's Ultrasound-on-Chip technology.
The partnership between Midjourney and Butterfly Network has significant implications for the company's revenue streams, with potential earnings of up to $74M over five years.
The Midjourney Medical division's full-body scanner is being positioned as a consumer-friendly medical tool, potentially offering a faster and more accessible alternative to traditional MRI scans, although clinical accuracy and regulatory approval remain uncertain.

Technical Analysis· Feb 26

$BFLY has a potential run back to $5 or higher with a strong setup.
The stock is primed for continuation with bulls in control, and buyers dominate the tape.
$BFLY has broken out above recent swing highs, with a bid holding above support, and is playable for continuation.

Generated by AI

Community

Of the messages about BFLY, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	75.38%	44.71%	45.41%	37.21%
Newcomers	24.62%	55.29%	54.59%	62.79%

Regulars· Sep 22

Needham initiates coverage of Butterfly Network with a buy rating and a $10 target price, citing the company's potential to expand into new medical-device markets and its core platform's multiple near-term growth catalysts.
The stock is expected to reach double-digit prices by the end of the year, with some regulars predicting it will reach $10 before the close of the year.
The stock's valuation is considered stretched in the short term, but long-term bulls believe the company's growth prospects and potential for expansion into new markets will justify its current price.

Newcomers· Sep 22

The price of $BFLY has been increasing, with a 20.1% gain today, and a 150% increase over the past year, according to the daily and yearly charts.
The stock's recent move is attributed to analyst initiation, with Needham initiating coverage at Buy with a $10.00 price target, and the filing accounts for the stock's price increase.
$BFLY's market capitalization has been validated by the stock's recent price increase, with a current market cap of $2.6 billion, and the company's development and commercialization of ultrasound imaging solutions is seen as a key factor in its success.

Generated by AI

Butterfly Network

Social

Sep 29

Bullish· Sep 22

Bearish· Jun 22

Earnings· Feb 26

Analysts· Jun 21

Announcements· Jun 19

Technical Analysis· Feb 26

Regulars· Sep 22

Newcomers· Sep 22

Evercore ISI initiates Butterfly Network stock with outperform rating

Butterfly Network: Strong Stock Performance For This Innovative Company (NYSE:BFLY)

Butterfly Network president & CEO Joseph DeVivo sells $59,866 stock

Butterfly Stock Retreats: What's Going On Today? - Butterfly Network (NYSE:BFLY)

Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains?

Butterfly Network (BFLY) Gets New ‘Buy’ Reco, Climbs 22%; Hedge Fund Holdings More-Than-Double

Also Discussed

Butterfly Network, Inc.

Company Information

Location

Evercore ISI initiates Butterfly Network stock with outperform rating

Butterfly Network: Strong Stock Performance For This Innovative Company (NYSE:BFLY)

Butterfly Network president & CEO Joseph DeVivo sells $59,866 stock

Butterfly Stock Retreats: What's Going On Today? - Butterfly Network (NYSE:BFLY)

Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains?

Butterfly Network (BFLY) Gets New ‘Buy’ Reco, Climbs 22%; Hedge Fund Holdings More-Than-Double

Also Discussed

Social

Sep 29

Bullish· Sep 22

Bearish· Jun 22

Earnings· Feb 26

Analysts· Jun 21

Announcements· Jun 19

Technical Analysis· Feb 26

Regulars· Sep 22

Newcomers· Sep 22